about
DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriersThe clinical management of BRCA1 and BRCA2 mutation carriersMultidisciplinary meeting on male breast cancer: summary and research recommendationsVariants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersThe utility of ductal lavage in breast cancer detection and risk assessmentGenome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer riskVariation in breast cancer risk in BRCA1 and BRCA2 mutation carriersIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersA functionally significant SNP in TP53 and breast cancer risk in African-American womenCommon genetic variants and modification of penetrance of BRCA2-associated breast cancerThe contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.Exploring the link between MORF4L1 and risk of breast cancer.Long-term risk of medical conditions associated with breast cancer treatmentAn international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.Counselling framework for moderate-penetrance cancer-susceptibility mutations.Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT studyCommon variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriersEvaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy.International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.Utilization of religious coping strategies among African American women at increased risk for hereditary breast and ovarian cancer.Breast-cancer risk in families with mutations in PALB2Clinical management of hereditary breast cancer syndromes.Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous studyBreast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2How genetic variant libraries effectively extend gene testing patents: implications for intellectual property and good clinical care.Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriersMortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers: an update
P50
Q21144874-D8E4D5B6-DA2D-4004-B44A-F21330AD0046Q22252596-0DF0AA7F-4366-491A-9578-77753DA7A57FQ22252596-CA5BE0D3-4BCA-4B6A-AC45-6DA13CC2D3DAQ24631800-AD48F241-8520-4BA2-894B-7AF54AA621A4Q24632704-9D352006-093A-4DEB-B9D7-BB2B266C50EBQ24655824-9108ED26-D81C-4515-A63C-8CBB0DEF5D17Q24802209-3D89334B-967F-4D28-8FC1-5EE1A5155068Q27008356-4F5BFC89-F0FA-4ACA-8C74-4CA2A45B7CC5Q28386156-A9A62533-C90E-4B77-B765-15F96FD2C169Q30252854-FDF35385-8958-46BE-9D44-C90AABDA9AF3Q30374367-E97B3CE8-B48D-4CA5-8D01-6109037880A8Q31043651-497ECD8F-3CAD-4106-961C-05D57B9F27F4Q33419302-97011D95-5F7A-409F-95D9-5DE3358A43CCQ33614244-03DECC71-84D3-400F-8B7F-0CF3B44CFD14Q33731355-0D830937-D82B-4EAE-A109-BC4031AC7E3BQ33742096-C1D1F068-6BF4-4115-A84B-D5A485A29E67Q33784408-F26C41A2-0B87-4782-B96A-1F4047BF789FQ33845209-1B140760-E949-4895-A09B-12C2006B8A53Q33863235-3F6327A7-7E86-4EE7-8ED6-DC11224C5A26Q33895877-4FE9AA01-016C-48DB-A8C4-699684FC0667Q33901361-96D44746-842B-4AEC-94AE-062CE2BE527FQ33911135-B7FCB8E2-75EE-40A9-8924-5D7D5054A053Q33927384-A740109E-0D88-4E72-985A-FC69CE3EC801Q33947829-7F3D504A-E300-4310-89A4-B26C598AE629Q34077422-8210747D-55B9-4DFC-BE7D-01B764F58A07Q34081324-646522E6-6214-45CC-A9DA-09DECBFDEB78Q34114943-A94942DD-5DB7-495B-B5A5-982017ECFFADQ34116505-A62140AC-58A8-49E3-9354-867FF6949A93Q34135443-2A54CCA2-E759-4D83-9C8F-AF5688F794F5Q34135634-55668B2C-51C2-4003-A5EC-C5CC99E4E784Q34148873-428C4FD2-4EC9-4B93-B121-282F36A024B4Q34167563-6D0CFFC7-B24A-4025-877D-CBB51807E944Q34172655-15D29F8F-DD54-4321-902D-A542BB1808D1Q34213403-C407D6C2-328B-4132-9F66-5CFD5B7CFA0AQ34311315-799B24EE-5464-48A8-B2F2-ED0C67D97DADQ34327945-A9539378-7386-4E50-BA92-832B068CDBA9Q34339288-48AD76D3-70E0-4C76-8FE7-21374ABE3B5CQ34394665-5105C6D5-8271-4D0B-AA12-AA7B19093A92Q34475484-2EF5348B-40F4-4A01-BDA2-E1786245CCF2Q34498634-CF13586C-E02F-4A79-94E5-053C7DDABDF1
P50
name
Susan M Domchek
@ast
Susan M Domchek
@en
Susan M Domchek
@nl
type
label
Susan M Domchek
@ast
Susan M Domchek
@en
Susan M Domchek
@nl
prefLabel
Susan M Domchek
@ast
Susan M Domchek
@en
Susan M Domchek
@nl